z-logo
open-access-imgOpen Access
Expression, activity and cytotoxicity of pertussis toxin S1 subunit in transfected mammalian cells
Author(s) -
Castro Monica G.,
McNamara Ulrike,
Carbonetti Nicholas H.
Publication year - 2001
Publication title -
cellular microbiology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.542
H-Index - 138
eISSN - 1462-5822
pISSN - 1462-5814
DOI - 10.1046/j.1462-5822.2001.00092.x
Subject(s) - biology , transfection , pertussis toxin , cytotoxicity , toxin , protein subunit , microbial toxins , virology , microbiology and biotechnology , cell culture , gene , genetics , in vitro , g protein , signal transduction
Pertussis toxin (PT) comprises an active subunit (S1), which ADP‐ribosylates the alpha subunit of several mammalian G proteins, and the B oligomer (S2–S5), which binds glycoconjugate receptors on cells. In a previous report, expression of S1 in Cos cells resulted in no observable cytotoxicity, and it was hypothesized that either S1 failed to locate its target proteins or the B oligomer was also necessary for cytotoxicity. To address this, we stably transfected S1 with and without a signal peptide into mammalian cells. Immunofluorescence analysis confirmed the function of the signal peptide. Surprisingly, we found that S1 was active in both transfectants, as determined by clustering of transfected Chinese hamster ovary (CHO) cells and ADP‐ribosylation of G proteins. Constructs with a cysteine‐to‐serine change at residue 201 or a truncated S1 (residues 1–181) were also active when transfected into cells. Constructs with an inactive mutant S1 had no activity, confirming that the observed results were due to the activity of the toxin subunit. We conclude that S1 is active when expressed in mammalian cells without the B oligomer, that secretion into the endoplasmic reticulum does not prevent this activity and that the C‐terminal portion of S1 is not required for its activity in cells.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here